Literature DB >> 32855541

circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.

Shu Xu1, San-Lin Lei1, Kui-Jie Liu1, Shen-Gen Yi1, Zhu-Lin Yang2, Hong-Liang Yao3.   

Abstract

Pancreatic cancer (PC) is one of the most common and lethal cancers that affects millions of people around the world. The prognosis of PC is poor with very limited effective treatments. Here, we fully investigated the function and underlying mechanism of circSFMBT1 (hsa_circ_0066147) in PC. Real-time quantitative PCR, Western blotting, and immunohistochemistry were used to examine levels of circSFMBT1, miR-330-5p, PAK1 (p21-activated kinase 1), or proliferation/metastasis-related proteins. Colony formation assay, flow cytometry, and transwell assay detected the roles of circSFMBT1 and miR-330-5p in cell apoptosis, proliferation, migration, and invasion of PC cells, respectively. Dual luciferase assay and RNA immunoprecipitation were used to validate the interactions of circSFMBT1/miR-330-5p and miR-330-5p/PAK1. Fluorescence in situ hybridization was performed to examine the subcellular localization of circSFMBT1 and miR-330-5p. Subcutaneous tumor growth was monitored in nude mice and in vivo metastasis was examined as well following injection of PC cells into the tail vein. This study demonstrated that circSFMBT1 and PAK1 were up-regulated in PC tissues and cells, while miR-330-5p was down-regulated. circSFMBT1 directly bound miR-330-5p and inhibited its expression. In addition, circSFMBT1 promoted proliferation, migration, and invasion of PC cells through up-regulating proliferation-related proteins and down-regulating apoptosis-related proteins via miR-330-5p. miR-330-5p directly bound PAK1 mRNA and suppressed proliferation, migration, invasion, and epithelial-mesenchymal transition process via targeting PAK1 in PC cells. Further, knockdown circSFMBT1 increased miR-330-5p level, but decreased PAK1 expression and repressed tumor growth and metastasis in vivo. Taken together, circSFMBT1 promotes proliferation and metastasis of PC via regulating miR-330-5p/PAK1 pathway as a miR-330-5p sponge.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32855541     DOI: 10.1038/s41417-020-00215-2

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  12 in total

Review 1.  Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star.

Authors:  Qun Chen; Jiajia Li; Peng Shen; Hao Yuan; Jie Yin; Wanli Ge; Wujun Wang; Guangbin Chen; Taoyue Yang; Bin Xiao; Yi Miao; Zipeng Lu; Pengfei Wu; Kuirong Jiang
Journal:  Cell Biosci       Date:  2022-06-21       Impact factor: 9.584

2.  Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells.

Authors:  Wenjing Ji; Xiaoyan Sun; Yang Gao; Man Lu; Lingxia Zhu; Dawei Wang; Chunping Hu; Jiao Chen; Peng Cao
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

3.  Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer.

Authors:  Xiaoxiao Zhou; Kun Liu; Jing Cui; Jiongxin Xiong; Heshui Wu; Tao Peng; Yao Guo
Journal:  J Exp Clin Cancer Res       Date:  2021-04-08

Review 4.  Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment.

Authors:  Zeyin Rong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype.

Authors:  Chen Fang; Xin Huang; Jun Dai; Wei He; Le Xu; Fukang Sun
Journal:  BMC Cancer       Date:  2022-04-08       Impact factor: 4.638

6.  Silencing of circRNA circ_0001666 Represses EMT in Pancreatic Cancer Through Upregulating miR-1251 and Downregulating SOX4.

Authors:  Rundong Zhang; Wanli Zhu; Chenchao Ma; Kaixing Ai
Journal:  Front Mol Biosci       Date:  2021-05-13

Review 7.  Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer.

Authors:  Xinzhu Sun; Dongyan Liu; Nan Ge; Jintao Guo; Sheng Wang; Xiang Liu; Guoxin Wang; Siyu Sun
Journal:  Cancer Manag Res       Date:  2021-05-28       Impact factor: 3.989

Review 8.  Circular RNAs as novel potential biomarkers for pancreatic cancer.

Authors:  Shanshan Liu; Qiuyue Li; Yan Ma; Christopher Corpe; Jin Wang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

9.  Mechanisms of circular RNA circ_0066147 on pancreatic cancer progression.

Authors:  Jie Zhang; Zhang Zhang
Journal:  Open Life Sci       Date:  2021-05-22       Impact factor: 0.938

Review 10.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.